Patents by Inventor Chien-Huang LIN

Chien-Huang LIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMINONAPHTHOQUINONE COMPOUNDS FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
    Publication number: 20240130984
    Abstract: The invention relates to the use of a compound of Formula (I) as described herein and its effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.
    Type: Application
    Filed: October 23, 2023
    Publication date: April 25, 2024
    Inventors: Yun YEN, Jing-Ping LIOU, Chien Huang LIN
  • Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases
    Patent number: 11833122
    Abstract: The invention relates to the use of a compound of Formula (I) as described herein and its effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: December 5, 2023
    Assignee: Calgent Biotechnology Co., Ltd.
    Inventors: Yun Yen, Jing-ping Liou, Chien Huang Lin
  • INDOLINE DERIVATIVES FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
    Publication number: 20220184032
    Abstract: The invention relates to the use of Indoline derivatives, and their effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.
    Type: Application
    Filed: March 2, 2022
    Publication date: June 16, 2022
    Inventors: Chien Huang LIN, Jing-Ping LIOU, Shiow-Lin PAN, Che-Ming TENG
  • Indoline derivatives for treatment and/or prevention of fibrosis diseases
    Patent number: 11278523
    Abstract: The invention relates to the use of Indoline derivatives, and their effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: March 22, 2022
    Assignee: Taipei Medical University
    Inventors: Chien Huang Lin, Jing-Ping Liou, Shiow-Lin Pan, Che-Ming Teng
  • AMINONAPHTHOQUINONE COMPOUNDS FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
    Publication number: 20180325845
    Abstract: The invention relates to the use of a compound of Formula (I) as described herein and its effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.
    Type: Application
    Filed: November 16, 2016
    Publication date: November 15, 2018
    Applicant: Taipei Medical University
    Inventors: Yun YEN, Jing-ping LIOU, Chien Huang LIN
  • INDOLINE DERIVATIVES FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES
    Publication number: 20180243264
    Abstract: The invention relates to the use of Indoline derivatives, and their effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.
    Type: Application
    Filed: October 27, 2015
    Publication date: August 30, 2018
    Applicant: Taipei Medical University
    Inventors: Chien Huang LIN, Jing Ping LIOU, Shiou Lin PAN, Che-Ming TENG
  • INDOLINE COMPOUNDS FOR TREATMENT AND/OR PREVENTION OF INFLAMMATION DISEASES
    Publication number: 20150368195
    Abstract: The invention is based on the discovery that 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines and 1-arylsulfonyl-5-(N-hydroxyacrylamide)indoles has great potential as a novel agent to be used in the treatment of inflammation-associated diseases, particularly, inflammatory arthritis and fibrosis.
    Type: Application
    Filed: June 20, 2014
    Publication date: December 24, 2015
    Inventors: Jing-Ping Liou, Chien-Huang Lin, Shiow-Lin Pan, Chia-Ron Yang, Che-Ming Teng
  • COMPOSITE TOUCH PANEL AND METHOD FOR OPERATING THE SAME
    Publication number: 20100141591
    Abstract: A composite touch panel includes a first insulating layer, a first conductive layer, a plurality of spacers, a second conductive layer and a second insulating layer in turn stacked on each other. The second conductive layer is applied with a predetermined first working voltage, and the voltages at four comers of the first conductive layer are measured. The composite touch panel is judged to work at a resistance mode when one of the measured voltages exceeds a first threshold, and a pressed position on the composite touch panel is determined. The composite touch panel is judged to work at a capacitance mode when all of the measured voltages are smaller than the first threshold. At the capacitance mode, whether a touch is present is judged, and the touch position is also determined when a touch is present.
    Type: Application
    Filed: December 9, 2008
    Publication date: June 10, 2010
    Inventor: Chien-Huang LIN